SBIR/STTR Research Award
Modulated Imaging in Comprehensive Assessment of Diabetic Foot Ulcer Development and Healing
Award amount
$1,824,517Program and phase
SBIR · Phase IIAward year
2016Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Modulated Imaging Inc.
- Proposal award date
- 2016-08-01
- Contract end date
- 2019-07-31
- UEI
- UHKMAAYPA486
- Solicitation number
- PA15-269
- Topic code
- 200
Research abstract
ABSTRACT
Diabetes mellitus affected million adults worldwide in and is expected to increase in
prevalence to million people by the year Foot ulceration continues to be a major
comorbidity of diabetes and afflicts as many as of subjects with type and diabetes
during their lifetime Lower limb amputations due to poor DFU management are a global burden
that is associated with a year mortality rate and cumulatively costs the system
approximately $ per patient Effective prevention and treatment of foot ulcers can be
hindered due to a lack of objective standards to quantitatively track foot health and assess
treatment outcomes The broad goal of this research is to develop Modulated Imaging a new
clinically viable tool which provides quantitative insight into disease stage progression and
therapeutic response into a clinically viable tool for screening and managing diabetic foot
ulcers MI is a non contact imaging technology that determines the in vivo concentrations of
subsurface chromophores relevant to tissue health i e hemoglobin oxygenation edema and
scattering The goal of this proposal is to develop a user friendly dedicated MI platform system
for studying the value of MI derived biometrics like hemoglobin oxygenation and scattering in
the diabetic foot In this Phase II program we will build a DFU MI device and perform three pilot
studies to assess the capability of our technology to impact diabetic foot care First we will
characterize vascular reactivity in control and feet considered at risk for ulcer to determine
normative MI biometrics Second we will study our ability to predict new wound formation in feet
that are considered in remission but with a andgt chance of re ulceration Finally we will study
lower limb perfusion changes after vascular intervention for and existing wound to assess
efficacy prior to wound closure Our Phase II research will determine the insertion point of MI
technology into DFU clinical care and provide insight to future Phase III clinical study
hypotheses and designs in order to build a medical imaging device with indications specific to
wound prediction and healing NARRATIVE
Effective prevention and treatment of foot ulcers can be hindered due to a lack of objective
standards to monitor progression The goal of this research is to develop Modulated Imaging a
new optical technology which provides quantitative insight into disease status and therapeutic
response into a clinically viable tool for screening and managing diabetic foot ulcers
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Real-time Modulated Imaging for Assessment of Tissue Viability Prior to Skin Grafts
- Modulated Imaging: Toward commercialization of a wide-field optical imaging platform for wound care
- The Development of a Low-Cost, Quantitative Skin Imaging Camera
- Modulated Imaging: A Wide-field Optical Imaging Platform for Clinical Research
- Modulated Imaging in Comprehensive Assessment of Diabetic Foot Ulcer Development